# H. B. Fuller Company (FUL) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Basic Materials / Chemicals. Price $53.89, market value $2.9 billion.

## Valuation
- **P/E (trailing): 16.0×** (5-yr avg 26.5×, 3-yr avg 26.8×). H. B. Fuller Company trades at 16.0× trailing earnings, well below its own five-year average of 26.5×: cheap by its own standards. The Basic Materials median in the September 2026 study was 19.0×. Forward P/E is 10.1×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.52**. A PEG of 0.52 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.8×**. Each dollar of revenue is priced at 0.8×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.4×**. The shares trade at 1.4× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 4.9%** (5-yr avg 4.2%). Free cash flow equals 4.9% of the market value, in line with its five-year average of 4.2%.
- **Earnings yield: 6.3%**. The inverse of the P/E: 6.3% of the price is earned each year.

## Profitability
- **Gross margin: 32.0%**. H. B. Fuller Company keeps 32.0% of revenue after the direct cost of what it sells.
- **Net margin: 4.4%**. 4.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 7.6%**. 7.6% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 3.6%**. Each dollar of assets produces 3.6% of profit.

## Growth
- **Revenue growth (1 yr): -2.7%** (3-yr -0.4%/yr, 5-yr 1.2%/yr). Revenue fell 2.7% over the last year, against 1.2% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 19.6%** (3-yr 2.0%/yr, 5-yr -1.5%/yr). Earnings per share rose 19.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -22.4%/yr**. Free cash flow has compounded at -22.4% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 1.01**. Debt is 1.01 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 1.82%** ($0.95 per share, trailing). H. B. Fuller Company yields 1.82%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 33%** (36% of free cash flow). 33% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 26**. 26 straight years of increases (the data covers 26 years, so this may be longer): a record very few companies hold.
- **Dividend growth (5 yr): 7.4%/yr** (1-yr 6.2%). The dividend has grown 7.4% a year over five years.

## Analyst view
- **Analyst consensus: strong_buy** (7 analysts). 7 analysts cover H. B. Fuller Company; the consensus is strong_buy, with an average price target of $73.29 (+36% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -11.0%** (YTD -8.7%, 3-mo -10.0%). The shares are down 11.0% over twelve months including dividends.
- **From 52-week high: -21.5%** (10.6% above the low). Trading 21% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 36**. An RSI of 36 is neutral.
- **Beta (1 yr): 1.04** (volatility 34%). Beta of 1.04 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=FUL · Page: https://foliofundamentals.com/stocks/ful

Not investment advice.
